Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash in escrow
Prepaid expense	29,100	1,875
Total current assets	29,100	1,875
Noncurrent assets
Marketable securities held in trust account	37,257,981	35,359,088
Total noncurrent assets	37,257,981	35,359,088
Total assets	37,287,081	35,360,963
Current liabilities:
Accrued expenses	408,763	298,280
Due to Sponsor	858,161	375,834
Promissory notes-related party	2,672,403	2,172,403
Total current liabilities	3,939,327	2,846,517
Noncurrent liabilities
Deferred underwriting commissions	2,875,000	2,875,000
Total noncurrent liabilities	2,875,000	2,875,000
Total liabilities	6,814,327	5,721,517
Commitments and contingencies (Note 6)
Ordinary shares subject to possible redemption, 3,202,416 and 11,500,000 shares at redemption value of $11.63 and $11.06 per share as of September 30, 2024 and December 31, 2023, respectively	37,257,981	35,409,088
Shareholders’ deficit:
Ordinary shares, par value $0.001, authorized 50,000,000 shares; 3,205,000 and 3,205,000 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively, excluding 3,202,416 and 11,500,000 shares subject to possible redemption at 30, 2024 and December 31, 2023, respectively	3,205	3,205
Accumulated deficit	(6,788,432)	(5,772,847)
Total shareholders’ deficit	(6,785,227)	(5,769,642)
Total liabilities, redeemable ordinary shares and shareholders’ deficit	$ 37,287,081	$ 35,360,963